Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.63
10.03.21
€62.35
10.03.22
28.85%
10.03.22

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.63
10.03.21
€62.35
10.03.22
28.85%
10.03.22

buy
GSK plc

Start price
Target price
Perf. (%)
€14.97
09.03.21
€22.00
09.03.22
25.18%
10.03.22

High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
buy
GSK plc

Start price
Target price
Perf. (%)
€14.97
09.03.21
€22.00
09.03.22
25.18%
10.03.22

High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€82.98
08.03.21
-
08.03.22
-72.98%
09.03.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€82.98
08.03.21
-
08.03.22
-72.98%
09.03.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€36.19
07.03.21
-
07.03.22
-62.14%
08.03.22

EBIT growth >5% per year expected
Capable Management
Could be worthwhile Investment >10% per year
Little innovation
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.80
05.09.21
-
05.09.22
-47.79%
07.03.22

Probably not worthwhile Investment
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.31
20.02.22
-
20.02.23
-6.49%
05.03.22

Risky Investment
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€29.39
20.02.22
-
20.02.23
-0.65%
05.03.22

Could be very worthwhile Investment >20% year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.85
20.02.22
-
20.02.23
-14.37%
05.03.22

Could be very worthwhile Investment >20% year
buy
GSK plc

Start price
Target price
Perf. (%)
€14.42
04.03.21
€21.55
04.03.22
26.39%
05.03.22

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
ROE higher than 10% per year
buy
GSK plc

Start price
Target price
Perf. (%)
€14.42
04.03.21
€21.55
04.03.22
26.39%
05.03.22

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
ROE higher than 10% per year
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.03
22.02.22
€1.00
22.02.23
-25.24%
05.03.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.40
01.03.22
-
01.03.23
2.48%
02.03.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€52.40
01.03.22
-
01.03.23
2.48%
02.03.22

buy
Codexis Inc.

Start price
Target price
Perf. (%)
€33.00
23.11.21
-
23.11.22
-46.36%
02.03.22

buy
Innoviva Inc.

Start price
Target price
Perf. (%)
€13.00
06.08.21
-
06.08.22
28.46%
02.03.22

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€33.45
05.12.21
€40.00
05.12.22
-27.32%
01.03.22

Could be worthwhile Investment >10% per year
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€33.45
05.12.21
€40.00
05.12.22
-27.32%
01.03.22

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.22
03.06.21
-
03.06.22
-2.82%
26.02.22

Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.22
03.06.21
-
03.06.22
-2.82%
26.02.22

Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.28
14.12.21
€0.000
14.12.22
-99.89%
20.02.22

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.53
06.02.22
-
06.02.23
-8.76%
20.02.22

Could be very worthwhile Investment >20% year